201 related articles for article (PubMed ID: 37543674)
21. Cuproptosis-related risk score predicts prognosis and characterizes the tumor microenvironment in colon adenocarcinoma.
Wang J; Tao Z; Wang B; Xie Y; Wang Y; Li B; Cao J; Qiao X; Qin D; Zhong S; Hu X
Front Oncol; 2023; 13():1152681. PubMed ID: 37333810
[TBL] [Abstract][Full Text] [Related]
22. Metabolism-related lncRNAs signature to predict the prognosis of colon adenocarcinoma.
Sun Y; Liu B; Xiao B; Jiang X; Xiang JJ; Xie J; Hu XM
Cancer Med; 2023 Mar; 12(5):5994-6008. PubMed ID: 36366731
[TBL] [Abstract][Full Text] [Related]
23. A novel enterocyte-related 4-gene signature for predicting prognosis in colon adenocarcinoma.
Cheng X; Wei Y; Fu Y; Li J; Han L
Front Immunol; 2022; 13():1052182. PubMed ID: 36532007
[TBL] [Abstract][Full Text] [Related]
24. Development of a prognostic model for personalized prediction of colon adenocarcinoma (COAD) patient outcomes using methylation-driven genes.
Chen D; Zhang B; Kang K; Li L; Liao Y; Qing S; Di Y
J Appl Genet; 2023 Dec; 64(4):713-721. PubMed ID: 37589877
[TBL] [Abstract][Full Text] [Related]
25. A Prognostic Model Based on the Immune-related Genes in Colon Adenocarcinoma.
Sun YL; Zhang Y; Guo YC; Yang ZH; Xu YC
Int J Med Sci; 2020; 17(13):1879-1896. PubMed ID: 32788867
[No Abstract] [Full Text] [Related]
26. An epithelial-mesenchymal transition-related mRNA signature associated with the prognosis, immune infiltration and therapeutic response of colon adenocarcinoma.
Zhang Y; Li Y; Zuo Z; Li T; An Y; Zhang W
Pathol Oncol Res; 2023; 29():1611016. PubMed ID: 36910014
[No Abstract] [Full Text] [Related]
27. Identification of cuproptosis-related subtypes, construction of a prognosis model, and tumor microenvironment landscape in gastric cancer.
Wang J; Qin D; Tao Z; Wang B; Xie Y; Wang Y; Li B; Cao J; Qiao X; Zhong S; Hu X
Front Immunol; 2022; 13():1056932. PubMed ID: 36479114
[TBL] [Abstract][Full Text] [Related]
28. Analysis of Interleukin-1 Signaling Alterations of Colon Adenocarcinoma Identified Implications for Immunotherapy.
Zhou X; Liu Y; Xiang J; Wang Y; Wang Q; Xia J; Chen Y; Bai Y
Front Immunol; 2021; 12():665002. PubMed ID: 34367132
[TBL] [Abstract][Full Text] [Related]
29. Construction and verification of a histone deacetylases-related prognostic signature model for colon cancer.
Hao L; Lu W; Wu J; Chen Y; Xu D; Wang P
Sci Rep; 2024 Apr; 14(1):8983. PubMed ID: 38637684
[TBL] [Abstract][Full Text] [Related]
30. A potential prognostic prediction model of colon adenocarcinoma with recurrence based on prognostic lncRNA signatures.
Jin L; Li C; Liu T; Wang L
Hum Genomics; 2020 Jun; 14(1):24. PubMed ID: 32522293
[TBL] [Abstract][Full Text] [Related]
31. Developing a prognosis and chemotherapy evaluating model for colon adenocarcinoma based on mitotic catastrophe-related genes.
Liu Y; Zhao Y; Zhang S; Rong S; He S; Hua L; Wang X; Chen H
Sci Rep; 2024 Jan; 14(1):1655. PubMed ID: 38238555
[TBL] [Abstract][Full Text] [Related]
32. Construction and Validation of a Reliable Disulfidptosis-Related LncRNAs Signature of the Subtype, Prognostic, and Immune Landscape in Colon Cancer.
Dong X; Liao P; Liu X; Yang Z; Wang Y; Zhong W; Wang B
Int J Mol Sci; 2023 Aug; 24(16):. PubMed ID: 37629096
[TBL] [Abstract][Full Text] [Related]
33. Identification of sixteen metabolic genes as potential biomarkers for colon adenocarcinoma.
Zhao F; Liu Y; Gu X; Zhang B; Song C; Cui B
J BUON; 2021; 26(4):1252-1259. PubMed ID: 34564978
[TBL] [Abstract][Full Text] [Related]
34. A novel signature model based on mitochondrial-related genes for predicting survival of colon adenocarcinoma.
Gao H; Xing F
BMC Med Inform Decis Mak; 2022 Oct; 22(1):277. PubMed ID: 36273131
[TBL] [Abstract][Full Text] [Related]
35. A novel prognostic gene set for colon adenocarcinoma relative to the tumor microenvironment, chemotherapy, and immune therapy.
Zhou H; Wang Y; Zhang Z; Xiong L; Liu Z; Wen Y
Front Genet; 2022; 13():975404. PubMed ID: 36699444
[No Abstract] [Full Text] [Related]
36. Prognostic significance and immune landscape of a fatty acid metabolism-related gene signature in colon adenocarcinoma.
Liu X; Fang X; Lu L; Liu G
Front Genet; 2022; 13():996625. PubMed ID: 36568396
[No Abstract] [Full Text] [Related]
37. System analysis based on the ER stress-related genes identifies WFS1 as a novel therapy target for colon cancer.
Yang X; Zhang C; Yan C; Ma L; Ma J; Meng X
Aging (Albany NY); 2022 Nov; 14(22):9243-9263. PubMed ID: 36445321
[TBL] [Abstract][Full Text] [Related]
38. In silico development and clinical validation of novel 8 gene signature based on lipid metabolism related genes in colon adenocarcinoma.
Jiang C; Liu Y; Wen S; Xu C; Gu L
Pharmacol Res; 2021 Jul; 169():105644. PubMed ID: 33940186
[TBL] [Abstract][Full Text] [Related]
39. Pyroptosis is related to immune infiltration and predictive for survival of colon adenocarcinoma patients.
Lu H; Sun Y; Zhu Z; Yao J; Xu H; Huang R; Huang B
Sci Rep; 2022 Jun; 12(1):9233. PubMed ID: 35655081
[TBL] [Abstract][Full Text] [Related]
40. A Risk Model for Prognosis and Treatment Response Prediction in Colon Adenocarcinoma Based on Genes Associated with the Characteristics of the Epithelial-Mesenchymal Transition.
Huang H; Li T; Meng Z; Zhang X; Jiang S; Suo M; Li N
Int J Mol Sci; 2023 Aug; 24(17):. PubMed ID: 37686013
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
